Cargando…

Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis

Objectives To determine the incidence of any and referable diabetic retinopathy in people with type 2 diabetes mellitus attending an annual screening service for retinopathy and whose first screening episode indicated no evidence of retinopathy. Design Retrospective four year analysis. Setting Scree...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, R L, Dunstan, F, Luzio, S D, Roy Chowdury, S, Hale, S L, North, R V, Gibbins, R L, Owens, D R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284424/
https://www.ncbi.nlm.nih.gov/pubmed/22362115
http://dx.doi.org/10.1136/bmj.e874
_version_ 1782224365238091776
author Thomas, R L
Dunstan, F
Luzio, S D
Roy Chowdury, S
Hale, S L
North, R V
Gibbins, R L
Owens, D R
author_facet Thomas, R L
Dunstan, F
Luzio, S D
Roy Chowdury, S
Hale, S L
North, R V
Gibbins, R L
Owens, D R
author_sort Thomas, R L
collection PubMed
description Objectives To determine the incidence of any and referable diabetic retinopathy in people with type 2 diabetes mellitus attending an annual screening service for retinopathy and whose first screening episode indicated no evidence of retinopathy. Design Retrospective four year analysis. Setting Screenings at the community based Diabetic Retinopathy Screening Service for Wales, United Kingdom. Participants 57 199 people with type 2 diabetes mellitus, who were diagnosed at age 30 years or older and who had no evidence of diabetic retinopathy at their first screening event between 2005 and 2009. 49 763 (87%) had at least one further screening event within the study period and were included in the analysis. Main outcome measures Annual incidence and cumulative incidence after four years of any and referable diabetic retinopathy. Relations between available putative risk factors and the onset and progression of retinopathy. Results Cumulative incidence of any and referable retinopathy at four years was 360.27 and 11.64 per 1000 people, respectively. From the first to fourth year, the annual incidence of any retinopathy fell from 124.94 to 66.59 per 1000 people, compared with referable retinopathy, which increased slightly from 2.02 to 3.54 per 1000 people. Incidence of referable retinopathy was independently associated with known duration of diabetes, age at diagnosis, and use of insulin treatment. For participants needing insulin treatment with a duration of diabetes of 10 years or more, cumulative incidence of referable retinopathy at one and four years was 9.61 and 30.99 per 1000 people, respectively. Conclusions Our analysis supports the extension of the screening interval for people with type 2 diabetes mellitus beyond the currently recommended 12 months, with the possible exception of those with diabetes duration of 10 years or more and on insulin treatment.
format Online
Article
Text
id pubmed-3284424
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-32844242012-02-28 Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis Thomas, R L Dunstan, F Luzio, S D Roy Chowdury, S Hale, S L North, R V Gibbins, R L Owens, D R BMJ Research Objectives To determine the incidence of any and referable diabetic retinopathy in people with type 2 diabetes mellitus attending an annual screening service for retinopathy and whose first screening episode indicated no evidence of retinopathy. Design Retrospective four year analysis. Setting Screenings at the community based Diabetic Retinopathy Screening Service for Wales, United Kingdom. Participants 57 199 people with type 2 diabetes mellitus, who were diagnosed at age 30 years or older and who had no evidence of diabetic retinopathy at their first screening event between 2005 and 2009. 49 763 (87%) had at least one further screening event within the study period and were included in the analysis. Main outcome measures Annual incidence and cumulative incidence after four years of any and referable diabetic retinopathy. Relations between available putative risk factors and the onset and progression of retinopathy. Results Cumulative incidence of any and referable retinopathy at four years was 360.27 and 11.64 per 1000 people, respectively. From the first to fourth year, the annual incidence of any retinopathy fell from 124.94 to 66.59 per 1000 people, compared with referable retinopathy, which increased slightly from 2.02 to 3.54 per 1000 people. Incidence of referable retinopathy was independently associated with known duration of diabetes, age at diagnosis, and use of insulin treatment. For participants needing insulin treatment with a duration of diabetes of 10 years or more, cumulative incidence of referable retinopathy at one and four years was 9.61 and 30.99 per 1000 people, respectively. Conclusions Our analysis supports the extension of the screening interval for people with type 2 diabetes mellitus beyond the currently recommended 12 months, with the possible exception of those with diabetes duration of 10 years or more and on insulin treatment. BMJ Publishing Group Ltd. 2012-02-22 /pmc/articles/PMC3284424/ /pubmed/22362115 http://dx.doi.org/10.1136/bmj.e874 Text en © Thomas et al 2012 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Research
Thomas, R L
Dunstan, F
Luzio, S D
Roy Chowdury, S
Hale, S L
North, R V
Gibbins, R L
Owens, D R
Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis
title Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis
title_full Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis
title_fullStr Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis
title_full_unstemmed Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis
title_short Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis
title_sort incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the diabetic retinopathy screening service for wales: retrospective analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284424/
https://www.ncbi.nlm.nih.gov/pubmed/22362115
http://dx.doi.org/10.1136/bmj.e874
work_keys_str_mv AT thomasrl incidenceofdiabeticretinopathyinpeoplewithtype2diabetesmellitusattendingthediabeticretinopathyscreeningserviceforwalesretrospectiveanalysis
AT dunstanf incidenceofdiabeticretinopathyinpeoplewithtype2diabetesmellitusattendingthediabeticretinopathyscreeningserviceforwalesretrospectiveanalysis
AT luziosd incidenceofdiabeticretinopathyinpeoplewithtype2diabetesmellitusattendingthediabeticretinopathyscreeningserviceforwalesretrospectiveanalysis
AT roychowdurys incidenceofdiabeticretinopathyinpeoplewithtype2diabetesmellitusattendingthediabeticretinopathyscreeningserviceforwalesretrospectiveanalysis
AT halesl incidenceofdiabeticretinopathyinpeoplewithtype2diabetesmellitusattendingthediabeticretinopathyscreeningserviceforwalesretrospectiveanalysis
AT northrv incidenceofdiabeticretinopathyinpeoplewithtype2diabetesmellitusattendingthediabeticretinopathyscreeningserviceforwalesretrospectiveanalysis
AT gibbinsrl incidenceofdiabeticretinopathyinpeoplewithtype2diabetesmellitusattendingthediabeticretinopathyscreeningserviceforwalesretrospectiveanalysis
AT owensdr incidenceofdiabeticretinopathyinpeoplewithtype2diabetesmellitusattendingthediabeticretinopathyscreeningserviceforwalesretrospectiveanalysis